ClinicalTrials.gg
TerminatedNCT04013100ParaCatIUpdated Jan 9, 2024

Cohort Trial on Perioperative Localization Techniques of Parathyroid Adenomas

An observational study in Primary Hyperparathyroidism, sponsored by IHU Strasbourg. Terminated. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-09.

Sponsored by IHU Strasbourg · Observational

Why this study was terminated
Departure of the main investigator
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
235
Ages
18 Years and older
Sex
All
01

Study summary

A prospective database of consecutive patients with hyperparathyroidism subject to surgery is created. Preoperative workup and operative findings are recorded in this registry to allow comprehensive analysis.

Read the detailed description

This is a non-interventional, prospective, monocentric, non-randomized trial. All patients with biochemically confirmed Primary Hyperparathyroidism (PHPT) who are scheduled for elective parathyroidectomy in the Endocrine and Digestive Surgery Unit of the University Hospital of Strasbourg are considered. Data concerning the age, the operative date, the results of the pre-operative biological work-up (plasma calcium, phosphor, parathyroid hormone (PTH) level, vitamin D), the results of pre-operative imaging (CT (computerized tomography) scan, 99mTc SestaMIBI Scan, 3D-Vitual Neck Exploration (VNE)), the operative data (the surgical approach, the localization and the dimensions of the adenoma (s), the necessity to convert to classical approach and its reason, the values of the intra operative PTH), the pathology results, the biological work-up at follow-up (plasma calcium, phosphor, PTH, vitamin D) are prospectively recorded in the database.

02

Conditions studied

  • Primary Hyperparathyroidism

Keywords

  • primary hyperparathyroidism
  • parathyroidectomy
  • 3D reconstruction
  • Virtual neck exploration
03

In context

Hyperparathyroidism, Primary

104 studies on the registry are indexed under Hyperparathyroidism, Primary; 23 are open to participants now.

This study's enrollment of 235 is above the median of 130 across 40 observational studies indexed under Hyperparathyroidism, Primary.

Browse Hyperparathyroidism, Primary studies →

Lead sponsor

IHU Strasbourg is the lead sponsor of 44 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients, male or female, with a confirmed biological diagnosis of primary hyperparathyroidism and for whom preoperative or intraoperative imaging is planned

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients with biochemically confirmed PHPT who are scheduled for elective parathyroidectomy
  2. Patient able to receive and understand trial information
  3. Patient affiliated with the French social security system

Exclusion criteria

Exclusion Criteria:

  1. Patient expressing opposition to the use, after anonymization, of medical data for scientific research
  2. Pregnant or breast-feeding woman
  3. Patient under guardianship or curatorship
  4. Patient under the protection of justice
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
235 participants (actual)
Target follow-up
1 Year
Patient registry
Yes

Interventions

  • Diagnostic test3D-VNE (virtual neck exploration)

    The 3D-VNE model is obtained with VP Planning software (Visible Patient, Strasbourg, France), using DICOM (Digital Imaging and Communications in Medicine) images of contrasted Computed Tomography scan of the neck in operative positioning.

06

What researchers measure

Primary outcomes

  1. Accuracy of 3D-VNE (virtual neck exploration) in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a 3D-VNE

    (true positives + true negatives) / number of patients

    Time frame: Surgery time

Secondary outcomes

  1. Sensitivity of 3D-VNE (virtual neck exploration) in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a 3D-VNE with positive confirmed results

    Sensitivity = True Positives / (True Positives + False Negatives)

    Time frame: Surgery time

  2. Specificity of 3D-VNE (virtual neck exploration) in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a 3D-VNE with negative confirmed results

    Specificity = True Negatives / (True Negatives + False Positives)

    Time frame: Surgery time

  3. Positive predictive value of 3D-VNE (virtual neck exploration) in indicating the localization of the parathyroid adenoma(s)

    Positive predictive value = True Positives / (True Positives + False Positives)

    Time frame: Surgery time

  4. Negative predictive value of 3D-VNE (virtual neck exploration) in indicating the localization of the parathyroid adenoma(s)

    Negative predictive value = True Negatives / (True Negatives + False Negatives)

    Time frame: Surgery time

  5. Accuracy of Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a Computed Tomography

    (True positives + True negatives) / number of patients

    Time frame: Surgery time

  6. Sensitivity of Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a Computed Tomography with positive confirmed results

    Sensitivity = True Positives / (True Positives + False Negatives)

    Time frame: Surgery time

  7. Specificity of Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a Computed Tomography with negative confirmed results

    Specificity = True Negatives / (True Negatives + False Positives)

    Time frame: Surgery time

  8. Positive predictive value of Computed Tomography in indicating the localization of the parathyroid adenoma(s)

    Positive predictive value = True Positives / (True Positives + False Positives)

    Time frame: Surgery time

  9. Negative predictive value of Computed Tomography in indicating the localization of the parathyroid adenoma(s)

    Negative predictive value = True Negatives / (True Negatives + False Negatives)

    Time frame: Surgery time

  10. Accuracy of 99mTc SestaMIBI Scan in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a 99mTc SestaMIBI Scan

    (True positives + True negatives) / number of patients

    Time frame: Surgery time

  11. Sensitivity of 99mTc SestaMIBI Scan in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a 99mTc SestaMIBI Scan with positive confirmed results

    Sensitivity = True Positives / (True Positives + False Negatives)

    Time frame: Surgery time

  12. Specificity of 99mTc SestaMIBI Scan in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a 99mTc SestaMIBI Scan with negative confirmed results

    Specificity = True Negatives / (True Negatives + False Positives)

    Time frame: Surgery time

  13. Positive predictive value of 99mTc SestaMIBI Scan in indicating the localization of the parathyroid adenoma(s)

    Positive predictive value = True Positives / (True Positives + False Positives)

    Time frame: Surgery time

  14. Negative predictive value of 99mTc SestaMIBI Scan in indicating the localization of the parathyroid adenoma(s)

    Negative predictive value = True Negatives / (True Negatives + False Negatives)

    Time frame: Surgery time

  15. Accuracy of cervical ultrasound in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a cervical ultrasound

    (True positives + True negatives) / number of patients

    Time frame: Surgery time

  16. Sensitivity of cervical ultrasound in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a cervical ultrasound with positive confirmed results

    Sensitivity = True Positives / (True Positives + False Negatives)

    Time frame: Surgery time

  17. Specificity of cervical ultrasound in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a cervical ultrasound with negative confirmed results

    Specificity = True Negatives / (True Negatives + False Positives)

    Time frame: Surgery time

  18. Positive predictive value of cervical ultrasound in indicating the localization of the parathyroid adenoma(s)

    Positive predictive value = True Positives / (True Positives + False Positives)

    Time frame: Surgery time

  19. Negative predictive value of cervical ultrasound in indicating the localization of the parathyroid adenoma(s)

    Negative predictive value = True Negatives / (True Negatives + False Negatives)

    Time frame: Surgery time

  20. Accuracy of cervical MRI in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a cervical MRI

    (True positives + True negatives) / number of patients

    Time frame: Surgery time

  21. Sensitivity of cervical MRI in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a cervical MRI with positive confirmed results

    Sensitivity = True Positives / (True Positives + False Negatives)

    Time frame: Surgery time

  22. Specificity of cervical MRI in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a cervical MRI with negative confirmed results

    Specificity = True Negatives / (True Negatives + False Positives)

    Time frame: Surgery time

  23. Positive predictive value of cervical MRI in indicating the localization of the parathyroid adenoma(s)

    Positive predictive value = True Positives / (True Positives + False Positives)

    Time frame: Surgery time

  24. Negative predictive value of cervical MRI in indicating the localization of the parathyroid adenoma(s)

    Negative predictive value = True Negatives / (True Negatives + False Negatives)

    Time frame: Surgery time

  25. Accuracy of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients

    (True positives + True negatives) / number of patients

    Time frame: Surgery time

  26. Sensitivity of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a Computed Tomography with positive confirmed results

    Sensitivity = True Positives / (True Positives + False Negatives)

    Time frame: Surgery time

  27. Specificity of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a Computed Tomography with negative confirmed results

    Specificity = True Negatives / (True Negatives + False Positives)

    Time frame: Surgery time

  28. Positive predictive value of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in indicating the localization of the parathyroid adenoma(s)

    Positive predictive value = True Positives / (True Positives + False Positives)

    Time frame: Surgery time

  29. Negative predictive value of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in indicating the localization of the parathyroid adenoma(s)

    Negative predictive value = True Negatives / (True Negatives + False Negatives)

    Time frame: Surgery time

  30. Accuracy of parathyroid autofluorescence detection in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients who underwent a parathyroid autofluorescence

    (True positives + True negatives) / number of patients

    Time frame: Surgery time

  31. Sensitivity of parathyroid autofluorescence detection in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a parathyroid autofluorescence detection with positive confirmed results

    Sensitivity = True Positives / (True Positives + False Negatives)

    Time frame: Surgery time

  32. Specificity of parathyroid autofluorescence detection in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients who underwent a parathyroid autofluorescence detection with negative confirmed results

    Specificity = True Negatives / (True Negatives + False Positives)

    Time frame: Surgery time

  33. Positive predictive value of parathyroid autofluorescence detection in indicating the localization of the parathyroid adenoma(s)

    Positive predictive value = True Positives / (True Positives + False Positives)

    Time frame: Surgery time

  34. Negative predictive value of parathyroid autofluorescence detection in indicating the localization of the parathyroid adenoma(s)

    Negative predictive value = True Negatives / (True Negatives + False Negatives)

    Time frame: Surgery time

  35. Accuracy of Intraoperative probe-based confocal endomicroscopy in indicating the localization of the parathyroid adenoma(s) assessed by the number of patients with confirmed results divided by the total number of patients

    (True positives + True negatives) / number of patients

    Time frame: Surgery time

  36. Sensitivity of Intraoperative probe-based confocal endomicroscopy in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients with positive confirmed results

    Sensitivity = True Positives / (True Positives + False Negatives)

    Time frame: Surgery time

  37. Specificity of Intraoperative probe-based confocal endomicroscopy in indicating the localization of the parathyroid adenoma(s) assessed by the ratio of patients with negative confirmed results

    Specificity = True Negatives / (True Negatives + False Positives)

    Time frame: Surgery time

  38. Positive predictive value of Intraoperative probe-based confocal endomicroscopy in indicating the localization of the parathyroid adenoma(s)

    Positive predictive value = True Positives / (True Positives + False Positives)

    Time frame: Surgery time

  39. Negative predictive value of Intraoperative probe-based confocal endomicroscopy in indicating the localization of the parathyroid adenoma(s)

    Negative predictive value = True Negatives / (True Negatives + False Negatives)

    Time frame: Surgery time

  40. Percentage of patients with minimally invasive parathyroidectomy approach

    Number of patients with minimally invasive parathyroidectomy/ total number of operated patients

    Time frame: Surgery time

  41. Percentage of patients with classical cervicotomy parathyroidectomy approach

    Number of patients with classical cervicotomy parathyroidectomy/ total number of operated patients

    Time frame: Surgery time

  42. Percentage of patients necessitating conversion from minimally invasive parathyroidectomy approach to classical cervicotomy

    Number of patients necessitating conversion from minimally invasive parathyroidectomy approach to classical cervicotomy / total number of operated patients

    Time frame: Surgery time

  43. Hyperparathyroidism recurrence rate

    Number of patients with recurrent / total number of operated patients

    Time frame: 1 year postoperatively

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Sessa L, Lombardi CP, De Crea C, Raffaelli M, Bellantone R. Video-assisted endocrine neck surgery: state of the art. Updates Surg. 2017 Jun;69(2):199-204. doi: 10.1007/s13304-017-0467-3. Epub 2017 Jun 15. PubMed 28620896 ↗
  • D'Agostino J, Diana M, Vix M, Nicolau S, Soler L, Bourhala K, Hassler S, Wu HS, Marescaux J. Three-dimensional metabolic and radiologic gathered evaluation using VR-RENDER fusion: a novel tool to enhance accuracy in the localization of parathyroid adenomas. World J Surg. 2013 Jul;37(7):1618-25. doi: 10.1007/s00268-013-2021-x. PubMed 23558758 ↗
  • D'Agostino J, Diana M, Vix M, Soler L, Marescaux J. Three-dimensional virtual neck exploration before parathyroidectomy. N Engl J Med. 2012 Sep 13;367(11):1072-3. doi: 10.1056/NEJMc1201488. No abstract available. PubMed 22970967 ↗
  • D'Agostino J, Wall J, Soler L, Vix M, Duh QY, Marescaux J. Virtual neck exploration for parathyroid adenomas: a first step toward minimally invasive image-guided surgery. JAMA Surg. 2013 Mar;148(3):232-8; discussion 238. doi: 10.1001/jamasurg.2013.739. PubMed 23682370 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04013100
Lead sponsor
IHU Strasbourg
Responsible party
Sponsor
First posted
Jul 9, 2019
Start date
Jan 1, 2014
Primary completion
Dec 31, 2018
Completion
Dec 31, 2018
Last update
Jan 9, 2024

Study contacts

Mihaela IGNAT, MD
principal investigator · Service Chirurgie Digestive et Endocrinienne, Nouvel Hôpital Civil de Strasbourg

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion